Kiniksa Pharmaceuticals International Insider Sold Shares Worth $835,555, According to a Recent SEC Filing
I'm PortAI, I can summarize articles.
04:42 PM EST, 12/17/2025 (MT Newswires) -- Barry D Quart, Director, on December 15, 2025, sold 20,129 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $835,555. Following the Form 4 filing with the SEC, Quart has control over a total of 12,546 Class A ordinary shares of the company, with 12,546 shares held directly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments